Crestwood Advisors Group LLC Sells 416 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Crestwood Advisors Group LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,868 shares of the financial services provider’s stock after selling 416 shares during the quarter. Crestwood Advisors Group LLC’s holdings in iShares Biotechnology ETF were worth $2,230,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Sequoia Financial Advisors LLC lifted its position in iShares Biotechnology ETF by 8.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock worth $380,000 after buying an additional 199 shares during the last quarter. NorthCrest Asset Manangement LLC raised its stake in shares of iShares Biotechnology ETF by 12.3% during the third quarter. NorthCrest Asset Manangement LLC now owns 3,290 shares of the financial services provider’s stock worth $479,000 after acquiring an additional 360 shares in the last quarter. Riggs Asset Managment Co. Inc. lifted its holdings in shares of iShares Biotechnology ETF by 1,314.0% in the 3rd quarter. Riggs Asset Managment Co. Inc. now owns 1,513 shares of the financial services provider’s stock worth $220,000 after acquiring an additional 1,406 shares during the last quarter. Traynor Capital Management Inc. boosted its stake in shares of iShares Biotechnology ETF by 11.2% in the 3rd quarter. Traynor Capital Management Inc. now owns 25,004 shares of the financial services provider’s stock valued at $3,641,000 after purchasing an additional 2,525 shares in the last quarter. Finally, Fidelis Capital Partners LLC grew its holdings in shares of iShares Biotechnology ETF by 8.4% during the 3rd quarter. Fidelis Capital Partners LLC now owns 5,253 shares of the financial services provider’s stock valued at $747,000 after purchasing an additional 409 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.1 %

Shares of NASDAQ:IBB opened at $138.74 on Tuesday. The company’s fifty day moving average is $135.64 and its 200 day moving average is $140.77. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.